MTOR and neoplasm: However, the integration of PI3K-IN-1 or Rapamycin to the therapeutic regimen exhibited a sensible reduction in these vascular indices, indicating that the pro-angiogenic effects of G-CSF are indeed modulated via the PI3K/AKT/mTOR pathway and attenuated SHP2 function within the tumor-nexus macrophages.